Term: | rifamycin SV |
|
Accession: | CHEBI:29673
|
browse the term
|
Definition: | A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. |
Synonyms: | exact_synonym: | (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate |
| related_synonym: | Formula=C37H47NO12; InChI=1S/C37H47NO12/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46)/b11-10+,14-13+,17-12-/t16-,18+,19+,20+,25-,29-,30+,33+,37-/m0/s1; InChIKey=HJYYPODYNSCCOU-ODRIEIDWSA-N; Rifamycin; Rifocin; Rifocyn; SMILES=CO[C@H]1\\C=C\\O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C; rifamicina; rifamycine; rifamycinum |
| xref: | CAS:6998-60-3; Drug_Central:4817; KEGG:C12044; KEGG:D02549; LIPID_MAPS_instance:LMPK05000005 |
| xref_mesh: | MESH:C023808 |
| xref: | MetaCyc:CPD-10236; PMID:25256628; Reaxys:5401012 |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:84571 |
|
|